MktsMarkets

enVVeno Medical Corporation
NASDAQ: NVNOKey statistics
NVNO News
Stories mentioning NVNO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 2,111 | 1,948 | 2,585 | 2,891 | 2,557 | 3,513 | 2,859 | 2,825 |
| Sales General & Admin | 1,951 | 2,065 | 2,298 | 4,158 | 2,397 | 3,186 | 3,311 | 2,629 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (4,062) | (4,013) | (4,883) | (7,049) | (4,954) | (6,699) | (6,170) | (5,454) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (3,849) | (3,736) | (4,539) | (6,694) | (4,503) | (6,229) | (5,642) | (4,956) |
| Earnings Per Share (Basic) | (5.89) | (6.34) | (0.23) | (0.33) | (7.75) | (12.71) | (0.35) | (0.31) |
| Earnings Per Share (Diluted) | (5.89) | (6.34) | (0.23) | (0.33) | (7.75) | (12.71) | (0.35) | (0.31) |
| Weighted Average Shares Outstanding (Basic) | 654.00 | 589.00 | 20,155 | 20,352 | 581.00 | 490.00 | 16,067 | 16,067 |
| Weighted Average Shares Outstanding (Diluted) | 654.00 | 589.00 | 20,155 | 20,352 | 581.00 | 490.00 | 16,067 | 16,067 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About NVNO
enVVeno Medical Corporation (NASDAQ: NVNO) is a stock listed on the Nasdaq Stock Market under the ticker symbol NVNO. It last traded at $5.25 (Nov 20, 2026, 9:30 AM ET), down 5.8% on the day. That gives enVVeno Medical a market capitalisation of $5.0M.
Over the past 52 weeks NVNO has traded between $5.22 and $14.66.
For the quarter ended Mar 31, 2026 it reported a net loss of $3.8M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$3.8M |
| Dec 31, 2025 | — | -$3.7M |
| Sep 30, 2025 | — | -$4.5M |
| Jun 30, 2025 | — | -$6.7M |
From enVVeno Medical’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…